Clearmind Medicine Announces Price of US$7.5 Million Public Offering and Listing on Nasdaq Capital Markets
VANCOUVER, Nov. 14, 2022 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq and CSE: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a biotechnology company focused on the discovery and development of new psychedelic-derived therapies to address important under-treated health conditions, today announced the price of its underwritten public offering of 1,153,847 common shares at a public …